Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs function by mimicking the inherent actions of GLP-1, a hormone produced by the https://zbookmarkhub.com/story20935895/reta-glucagon-like-peptide-1-receptor-agonists